The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines.

MLA

Owosho, Adepitan A., et al. “The Role of Parotid Gland Irradiation in the Development of Severe Hyposalivation (Xerostomia) after Intensity-Modulated Radiation Therapy for Head and Neck Cancer: Temporal Patterns, Risk Factors, and Testing the QUANTEC Guidelines.” Journal of Cranio-Maxillofacial Surgery, vol. 45, no. 4, Apr. 2017, pp. 595–600. EBSCOhost, https://doi.org/10.1016/j.jcms.2017.01.020.

APA

Owosho, A. A., Thor, M., Oh, J. H., Riaz, N., Tsai, C. J., Rosenberg, H., Varthis, S., Yom, S. H. K., Huryn, J. M., Lee, N. Y., Deasy, J. O., & Estilo, C. L. (2017). The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines. Journal of Cranio-Maxillofacial Surgery, 45(4), 595–600. https://doi.org/10.1016/j.jcms.2017.01.020

Chicago

Owosho, Adepitan A., Maria Thor, Jung Hun Oh, Nadeem Riaz, C. Jillian Tsai, Haley Rosenberg, Spyridon Varthis, et al. 2017. “The Role of Parotid Gland Irradiation in the Development of Severe Hyposalivation (Xerostomia) after Intensity-Modulated Radiation Therapy for Head and Neck Cancer: Temporal Patterns, Risk Factors, and Testing the QUANTEC Guidelines.” Journal of Cranio-Maxillofacial Surgery 45 (4): 595–600. doi:10.1016/j.jcms.2017.01.020.